Keynote speaker: Michelle M. Mielke, PhD, Chair of the Department of Epidemiology and Prevention, Professor of Epidemiology, and Professor of Gerontology and Geriatric Medicine, Wake Forest University School of Medicine
More details about the 2024 ACT Research Symposium may be found on our event page (login required).
To access the schedule for the 2024 ACT Research Symposium, check out program content on Whova.
The Whova app for event can be downloaded for more features.
Get Whova Now or use the QR code for download
Tuesday, May 14th: Symposium Day 1 |
|||
Speaker(s) |
Topic |
Presentation |
|
Michelle Mielke |
Keynote: Alzheimer’s blood-based biomarkers: ready for prime time? |
||
Will Bowers, Lily Shapiro |
ACT Project 2 presentation: Natural language processing and the medical record: methodological approaches to qualitative research with people with dementia |
||
Laura Harrington, Sarah Tom |
History of Adverse Pregnancy Outcomes and Cognitive Decline |
||
Victoria Marshe |
A human microglial atlas of expression programs in neurodegenerative disease and their transcriptional regulators |
||
Kacie Deters |
Disparities in risk factors for brain aging and ADRD |
||
Linda McEvoy, Aaron Seitz |
ACT Clinical Core presentation; Updates related to recruitment, biorepository, and workgroups |
||
Shelly Gray, Elizabeth Phelan |
Stop Falls Study |
||
Tim Hohman |
Molecular drivers of Alzheimer’s disease resilience through genomic and proteomic analyses |
Wednesday, May 15th: Symposium Day 2 |
|||
Speaker(s) |
Topic |
Presentation |
|
Cecilia Lee |
Tribute to Laura Gibbons |
||
Kelly Chang |
Advanced diffusion modeling characterizes FLAIR white matter hyperintensities in the ACT prospective neuroimaging cohort |
||
Maximilian Kobiesa |
Quantitative measurements of magnetic resonance angiography decrease with aging and cognitive impairment in the ACT cohort |
||
Chuxuan Sun |
Health care utilization and cost differences across cognitively-defined Alzheimer’s disease subgroups |
||
Kristen Russ |
NCRAD plasma and CSF ADRD biomarkers |
||
Joshua Sonnen |
Airborne metals, neurodegeneration, and dementia in the ACT study |